We are monitoring the impact of COVID-19 & Recession alarm on North America Varicose Vein Treatment Market Get in touch with us for detailed analysis Know More
Share on

North America Varicose Vein Treatment Market Research Report – Segmented By treatment Type, Device, End-User and Country (the United States, Canada and Rest of North America) - Industry Analysis on Size, Share, COVID-19 Impact, Growth, Trends, And Forecast (2022 to 2027)

Published: January, 2022
ID: 2506
Pages: 130

North America Varicose Vein Treatment Market Size (2022 to 2027)

The North American Varicose Vein Treatment Market is predicted to worth USD 166.12 million by 2027 and USD 122.39 million in 2022, growing at a CAGR of 6.3% from 2022 to 2027.

The varicose vein treatment market is growing due to the increased prevalence of varicose veins. This condition of enlarged veins appears mostly in the feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders, and high blood pressure.


The market for varicose vein treatment in North America is fuelled by reduced trauma, greater exposure to the site of application, high operative success rates, faster blood flow restoration, improved patient compliance & reliability, growing healthcare expenditure, and rapid growth of the aging population. 

Additionally, due to the growing prevalence of varicose vein cases, high disposable income, improved healthcare infrastructure, emerging diseases, and an upward tendency to adopt unhealthy lifestyles, North America had a high demand for the varicose vein treatment market. The industry is projected to develop even faster if reimbursement regulations in the United States are becoming more progressive. The market is driven by factors such as increased incidence of varicose vein disease, an increase in the geriatric population, advanced varicose vein treatment devices, participation in professions that increase the prevalence of varicose vein treatment, and global technological advancements. Varicose veins are associated with obesity, which is one of the risk factors. Obesity is a result of urbanization and a poor diet. As a result, the worldwide varicose vein treatment market is expected to be driven by an increase in people suffering from obesity.

The North American varicose vein treatment market is further anticipated to grow due to increased demand for technologically sophisticated products and a demand for less invasive methods. As a result, industry companies are focusing on developing solutions to enhance the treatment of varicose veins. Doctors can use laser ablation technology to close smaller varicose and spider veins. Strong bursts of light are directed towards the affected veins, causing them to disappear or fade. The local laser producers who specialize in varicose vein lasers are in fierce competition. The market is projected to increase in the future due to upcoming advances in lasers and the simplicity of treatment. As a result, throughout the forecast period, a rise in awareness is expected to boost the North America varicose vein treatment market.

Some of the major constraints limiting market growth include a scarcity of vascular surgeon training, the high cost of varicose vein treatment operations, and the adoption of healthcare reforms in the United States. The development of the varicose veins treatment industry has been hampered by a lack of effective diagnostic methods and a lack of awareness among the patient population.

The market's growth is also limited by challenges such as inconsistent reimbursement scenarios for varicose vein treatment procedures and the viability of businesses in a highly competitive market. Varicose veins are common in the general population, although the diagnostic rate is poor. As a result, the North America varicose vein treatment market's growth is restrained by a lower diagnosis rate, which reduces the treatment rate for varicose veins among patients.

This research report segmented and sub-segmented the North America Varicose Vein Treatment Market into the following categories and evaluated market size and forecast to each segment until 2027.

By treatment Types: 

  • Surgical Treatments
    • Vein Ligation and Stripping
    • Phlebectomy
  • Non-Surgical Treatments
    • Laser Therapy
    • Trans-Illuminated Powered Phlebectomy (Trivex)
  • Radiofrequency Ablation
    • Sclerotherapy

By Device: 

  • Ablation devices
    • Radiofrequency Ablation Devices
    • Laser Ablation Devices
  • Venous Closure Products
  • Surgical Products

By End-User: 

  • Surgery Centers
  • Hospitals
    • Specialty Hospitals
    • Multispecialty Hospitals

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, the North American market accounted for the largest share in the global market in 2020. Due to the growing elder people population, advanced technologies for treating varicose veins propel market growth. The ever-increasing number of key players coming up with new technologies, new product launches, and the growing number of people suffering from varicose vein disease propels the market growth during the period.

The U.S. varicose vein treatment market is leading the North American market. It is primarily attributed to the standard increase of varicose veins and various venous insufficiencies in the United States. Increasing stipulation for minimally invasive and effective healing interruption among the patient population accelerates the market growth of varicose vein treatment. Favorable reimbursement policies of the United States boost the market.

The Canadian varicose vein treatment market is projected to grow at a healthy rate during the forecast period. High disposable income, advantages of early diagnosis and treatment of varicose veins, and advanced healthcare infrastructure are majorly supporting the market growth in Canada.


A few of the promising companies leading the North America varicose vein treatment market profiled in the report are Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), Merz Aesthetics (U.S.).


                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Endovenous ablation          

                                5.1.3 Surgical litigation/ Stripping              

                                5.1.4 Sclerotherapy        

                                5.1.5  Y-o-Y Growth Analysis, By Treatment         

                                5.1.6  Market Attractiveness Analysis, By Treatment       

                                5.1.7  Market Share Analysis, By Treatment        

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Ablation devices   

                                       Radiofrequency ablation devices

                                       Laser ablation devices

                                5.2.3 Venous closure products  

                                5.2.4 Surgical products  

                                5.2.5 Y-o-Y Growth Analysis, By Product               

                                5.2.6 Market Attractiveness Analysis, By Product             

                                5.2.7 Market Share Analysis, By Product               

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Treatment

                                       By Product

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Treatment

                                       By Product

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Treatment

                                       By Product

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Medtronic plc                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AngioDynamics, Inc.                               

                8.3 Syneron Medical Ltd.                             

                8.4 Lumenis Ltd.                              

                8.5 Dornier MedTech GmbH                      

                8.6 Energist Group                          

                8.7 Vascular Solutions, Inc.                          

                8.8 Merz Aesthetics                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          


                a) List of Tables                

                b) List of Figures                              

  1. North America Varicose vein treatment Market, By Treatment, From 2022 - 2027 (USD Billion)
  2. North America Endovenous ablation Market, By Region, From 2022 - 2027 (USD Billion)
  3. North America Surgical litigation/ Stripping Market, By Region, From 2022 - 2027 (USD Billion)
  4. North America Sclerotherapy Market, By Region, From 2022 - 2027 (USD Billion)
  5. North America Varicose vein treatment Market, By Product, From 2022 - 2027 (USD Billion)
  6. North America Ablation devices Market, By Region, From 2022 - 2027 (USD Billion)
  7. North America Venous Closure products Market, By Region, From 2022 - 2027 (USD Billion)
  8. North America Surgical products Market, By Region, From 2022 - 2027 (USD Billion)
  9. United States Varicose vein treatment Market, By Treatment, From 2022 - 2027 (USD Billion)
  10. United States Varicose vein treatment Market, By Product, From 2022 - 2027 (USD Billion)
  11. Canada Varicose vein treatment Market, By Treatment, From 2022 - 2027 (USD Billion)
  12. Canada Varicose vein treatment Market, By Product, From 2022 - 2027 (USD Billion)
  13. North America Varicose vein treatment Market, By Ablation devices, From 2022 - 2027 (USD Billion)
  14. North America Radiofrequency Ablation Devices Market, By Region, From 2022 - 2027 (USD Billion)
  15. North America Laser Ablation Devices Market, By Region, From 2022 - 2027 (USD Billion)
  16. United States Varicose vein treatment Market, By Ablation devices, From 2022 - 2027 (USD Billion)
  17. Canada Varicose vein treatment Market, By Ablation devices, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample